145 results on '"Jentzsch M"'
Search Results
2. Efficacy and safety of bemcentinib in patients with advanced myelodysplastic neoplasms or acute myeloid leukemia failing hypomethylating agents- the EMSCO phase II BERGAMO trial
3. The Underwater Berlin Research Turbine: A Wind Turbine Model for Wake Investigations in a Water Towing Tank
4. Challenges and procedures for experiments with steady and unsteady model velocities in a water towing tank
5. Cellular dynamics and their impact on outcome in patients with mantle cell lymphoma during treatment with chimeric antigen receptor (CAR) T cells
6. Prognostic impact of the European LeukemiaNet standardized reporting system in older AML patients receiving stem cell transplantation after non-myeloablative conditioning
7. P509: CLONAL HEMATOPOIESIS-ASSOCIATED MUTATIONS AS MEASURABLE RESIDUAL DISEASE MARKERS IN ACUTE MYELOID LEUKEMIA PATIENTS FOLLOWING ALLOGENEIC STEM CELL TRANSPLANTATION
8. P1381: EARLY FULL DONOR CHIMERISM AFTER FLAMSA RIC BASED ALLOGENEIC HSCT BUT NOT PRESENCE OF MORPHOLOGICAL REMISSION ASSOCIATES WITH OUTCOMES IN R/R AML PATIENTS
9. S287: FACTORS INFLUENCING AUTOLOGOUS LYMPHOCYTE COLLECTIONS FOR CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS – THE ROLE OF T-CELL SENESCENCE
10. P1313: PREDICTING OUTCOMES IN AML PATIENTS CONSOLIDATED BY AN ALLOGENEIC STEM CELL TRANSPLANTATION USING THE KNOWLEDGE BANK APPROACH
11. P1356: PATIENT-SPECIFIC DIGITAL DROPLET PCR ASSAYS FOR MINIMAL RESIDUAL DISEASE DETECTION OF RUNX1 MUTATIONS IN ACUTE MYELOID LEUKEMIA PATIENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION
12. P007 ORMDL proteins shape homeostasis in the intestinal epithelium by regulating endoplasmic reticulum architecture and autophagy
13. Ernährung bei Niereninsuffizienz: Spagat zwischen Nephroprotektion und Vermeidung einer Malnutrition
14. Incidence of louse flies on birds from the Russian Far East (Diptera: Hippoboscidae) and investigation of the status of some taxa by DNA barcoding
15. PS1339 UNSUPERVISED HIERARCHICAL CLUSTERING OF PRE-TREATMENT IMMUNOPHENOTYPIC FEATURES IDENTIFIES MDS PATIENTS AT HIGH RISK OF DISEASE PROGRESSION AFTER ALLOGENEIC TRANSPLANTATION
16. STEM CELL MOBILIZATION AND AUTOLOGOUS STEM CELL TRANSPLANTATION AFTER BENDAMUSTINE, PREDNISONE AND BORTEZOMIB INDUCTION IN MULTIPLE MYELOMA PATIENTS WITH RENAL IMPAIRMENT.
17. Die Rolle der NADPH-Oxidasen NOX1 und p22phox in frühkindlicher CED
18. Metabolische Azidose: Wechselwirkungen zwischen Ernährung, Proteinund Muskelstoffwechsel
19. Management des renalen Hyperparathyreoidismus
20. Das Zusammenspiel aus Autophagie und ER-Stress koordiniert protektive IL-22-Signale im intestinalen Epithel
21. Stem Cell Mobilization and Autologous Stem Cell Transplantation after Pretreatment consisting of Bendamustine, Prednisone and Bortezomib (BPV) in 35 Patients with newly diagnosed/untreated Multiple Myeloma
22. Successful Treatment of Patients With Newly Diagnosed/Untreated Light Chain Multiple Myeloma With a Combination of Bendamustine; Prednisone and Bortezomib (BPV)
23. Prospektive 2-Jahresstudie zum Malnutritions- Inflammations-Arteriosklerose (MIA)-Syndrom bei Hämodialysepatienten: Inflammationsassoziierte Malnutrition ist ein signifikanter Mortalitätsprädiktor
24. Chronische und dialysepflichtige Niereninsuffizienz vom Stadium III bis Stadium VD â Was ist diagnostisch sinnvoll und wann? Welche Vitamin-D-Form, welches PTH, welche alkalische Phosphatase messen?
25. Rote Liste der Schwebfliegen (Diptera: Syrphidae) des Landes Sachsen-Anhalt
26. Ernährung bei Niereninsuffizienz
27. Occurrence of plasmids in black-pigmented Gram-negative anaerobes
28. Antimicrobial activities of black-pigmented Gram-negative anaerobes
29. Occurrence of plasmids in black-pigmented Gram-negative anaerobes.
30. Antimicrobial activities of black-pigmented Gram-negative anaerobes.
31. Thiamine-Responsive Megaloblastic Anemia (TRMA) Syndrome mimicking myelodysplastic neoplasm (MDS).
32. Azacitidine in combination with shortened venetoclax treatment cycles in patients with acute myeloid leukemia.
33. Bispecific antibodies as bridging to BCMA CAR-T cell therapy for relapsed/refractory multiple myeloma.
34. MoReLife - real-life data support the potential of momelotinib as a safe and effective treatment option for cytopenic myelofibrosis patients.
35. Impact of Previous Allogeneic Hematopoietic Stem Cell Transplantation on Chimeric Antigen Receptor (CAR) T Cell Treatment for Relapsed/Refractory Multiple Myeloma.
36. Single-cell multiomic dissection of response and resistance to chimeric antigen receptor T cells against BCMA in relapsed multiple myeloma.
37. Hematopoietic cell transplantation for older acute myeloid leukemia patients in first complete remission: results of a randomized phase III study.
38. Platelet transcription factors license the pro-inflammatory cytokine response of human monocytes.
39. Synthetic RIG-I agonist-mediated cancer immunotherapy synergizes with MAP kinase inhibition against BRAF-mutated melanoma.
40. Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee.
41. Optimising postoperative care: Same-day discharge after transurethral resection of the prostate.
42. Detection of Bartonella schoenbuchensis (sub)species DNA in different louse fly species in Saxony, Germany: The proof of multiple PCR analysis necessity in case of ruminant-associated bartonellae determination.
43. Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis: A retrospective analysis of the DRST and GREM registries.
44. Analysis of the peel structure of different Citrus spp. via light microscopy, SEM and μCT with manual and automatic segmentation.
45. Quantifying NPM1 MRD in AML patients prior to allogeneic stem cell transplantation: Where to draw the line?
46. Red blood cell distribution width (RDW) is associated with unfavorable functional outcome after transfemoral transcatheter aortic valve implantation.
47. Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma.
48. Management of Patients Undergoing CAR-T Cell Therapy in Germany.
49. Prognostic impact of measurable residual clonal hematopoiesis in acute myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation.
50. Design principles for cyclin K molecular glue degraders.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.